Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Ultralife (ULBI) Shares Issued (2016 - 2025)

Ultralife has reported Shares Issued over the past 15 years, most recently at $37000.0 for Q3 2025.

Quarterly results put Shares Issued at $37000.0 for Q3 2025, up 54.17% from a year ago — trailing twelve months through Dec 2025 was $98000.0 (down 95.1% YoY), and the annual figure for FY2025 was $98000.0, down 95.1%.
Shares Issued for Q3 2025 was $37000.0 at Ultralife, down from $61000.0 in the prior quarter.
Over the last five years, Shares Issued for ULBI hit a ceiling of $1.3 million in Q2 2024 and a floor of $3000.0 in Q3 2022.
Median Shares Issued over the past 5 years was $73000.0 (2021), compared with a mean of $275642.9.
Biggest five-year swings in Shares Issued: skyrocketed 32533.33% in 2023 and later plummeted 97.55% in 2024.
Ultralife's Shares Issued stood at $84000.0 in 2021, then tumbled by 96.43% to $3000.0 in 2022, then skyrocketed by 6800.0% to $207000.0 in 2023, then tumbled by 81.16% to $39000.0 in 2024, then fell by 5.13% to $37000.0 in 2025.
The last three reported values for Shares Issued were $37000.0 (Q3 2025), $61000.0 (Q2 2025), and $39000.0 (Q4 2024) per Business Quant data.